Abstract
New onset or exacerbation of psoriasis vulgaris has been reported in a small number of patients after interferon (IFN)-α therapy. Herein, we report a case of generalized flare of pustular psoriasis induced by PEGylated IFN-α2b (PEG-IFN-α2b) in a 59-year-old woman with a 15-year history of pustular psoriasis and chronic hepatitis C. Interferon-α therapy was discontinued and the rash resolved after treatment with cyclosporin and systemic methylprednisolone. The potential side effect of PEG-IFN-α2b in inducing or exacerbating psoriasis should be kept in mind when treating patients with a history of psoriasis or pustular psoriasis.
| Original language | English |
|---|---|
| Pages (from-to) | e69-e72 |
| Journal | Australasian Journal of Dermatology |
| Volume | 53 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 2012 Nov |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Dermatology
Fingerprint
Dive into the research topics of 'Generalized flare of pustular psoriasis induced by PEGylated interferon-α2b therapy for chronic hepatitis C'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver